Open house contract for the active substance "dapagliflozin, ATC code: A10BK01" for the period from 01.01.2023 to 30.11.2024.

The subject of this publication is the conclusion of contracts pursuant to § 130a Abs. 8 SGB V for an active substance within the framework of a so-called open-house procedure. Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the conclusion or accession to a discount agreement according to § 130a Abs. 8 SGB V for the mentioned active ingredient. The earliest contract start is 01.01.2023, contract end is 30.11.2024. Joining this open-house procedure is possible at any time during the term of the contract.